layout engjgh-foundation.s3.amazonaws.com/production/2018/06/27/19/...18 in hebrew letters forms the...

CELEBRATING THE PAST ANDSECURING THE FUTURE

ANNUAL REPORTincluding

Complete CampaignProgress Report

2016 17

Celebrating thePast and Securingthe Future

2018 is a Chai year, as the number 18 in Hebrew letters forms the word "chai", meaning "life".

Since 1934, the Jewish General Hospital (JGH) has been actively involved in preserving, saving and extending life for thousands of people throughout Quebec, regardless of race, colour or ethnic origin.

Today, 84 years later, the JGH plays a central and critical role in Montreal's healthcare system. This, in large measure, is the result of the dedi-

cation of its medical practitioners, nursing and ancillary staff, the vision and entre-preneurial spirit of its leaders and the generosity of its community.

While 2015 brought in new and additional changes to the structure of Quebec's health system, the JGH continues to play a central role. The Emergency Depart-ment, the Institute of Community and Family Psychiatry, the Segal Cancer Centre, the Azrieli Heart Centre, the Lady Davis Institute, the Eileen & Louis Dubrovsky Molecular Pathology and Microbiology Centre leading the way to personalized medicine, the latest robotic surgery procedures and many other specialized depart-ments and services all fortify the JGH’s place at the forefront of best medicine for the people of our city.

Hospitals of the future may be different from what we know today. The JGH is fortunate that its medical, administrative and volunteer leadership have both the vision and determination to ensure that our institution not only remains at the fore-front of medical innovation, but also ensures best practices in all its activities.

JGH FOUNDATION ANNUAL REPORT 2016-17 01

Myer BickPresident & CEOJGH Foundation

Howard DermerPast ChairJGH Foundation

Edward WiltzerChairJGH Foundation

Howard Dermer,Edward Wiltzer andMyer Bick

2017Foundation

OutstandingServiceAwards

02 JGH FOUNDATION ANNUAL REPORT 2016-17

The JGH Foundation Outstanding Service Award is bestowed upon exceptional individuals who have been actively involved in and made significant contributions in terms of promoting the mission of the Foundation, advancing its goals, and contributing to the betterment of the Jewish General Hospital. This year, on the occa-sion of the Foundation’s Annual General Meeting held on September 18, 2017, the Award was presented to two remarkable individuals: Pierre Brosseau and Ronny Steinberg.

Pierre Brosseau is a perfect example of an individual who has made a major and significant contribution to the work of the Foundation. A generous and multi-talented businessman, Pierre could have volunteered to lend his expertise to any charitable organization. Thankfully, he chose the Jewish General Hospital, which has been extremely beneficial for all of us!

Always well groomed and in fashionable attire, Pierre is the embodiment of a dynamic entrepreneur. He exudes energy, creativity and action.

Pierre joined the Foundation as a Trustee in 2012, and was elected to the Board of Directors and its Executive Committee in 2014. He was appointed to the position of Secretary in 2016. He also did yeomen’s work as Vice-Chair of the hospital’s Capital Campaign.

In the past six years, Pierre took it upon himself to organize the Festin de Babette, a gastronomic event that has raised over $3 million in support of Alzheimer’s disease research at the JGH.

His charming personality, his sharp intellect and fine character continue to elevate our Foundation deliberations.

Volunteers are essential to the ongoing

success of the JGH Foundation. The JGH

Foundation Outstanding Service Award

was created to recognize exemplary

service, to encourage volunteers to

contribute to the institution and to

promote the value of volunteerism and

community service to the individual

and to society at large.

(From left)Pierre Brosseau, Myer Bick, President & CEO of the JGH Foundation,Harvey Levenson, Co-Chair of the JGH Foundation Capital Campaign,Howard Dermer, President of the JGH Board of Governors,and Edward Wiltzer, JGH Foundation Chair.


Ronny Steinberg was appointed a Trustee in 2012 and has served as a member of our Board of Directors and Executive Committee since 2015. He is also a member of the Foundation's Grants Committee.

In 2011, he accepted the position of Chair of the Audit Committee and has held this position until today. His attention to detail, his understanding of the complex administrative, political and financial issues confronting the Foundation, the Hospital and government have greatly contributed to better management, which in turn advanced the Hospital’s and Foundation's mission.

He conducts his meetings with efficiency, intelligence and grace. Under his tutelage, audit meetings, where 25 to 30 pages of data are reviewed by 10 to 12 financial wizards, begin promptly and end 60 minutes later... not 61.

His involvement with the JGH includes membership in the Hospital's Advisory Committee and the President's Advisory Committee. In addition, he is also a member of the CIUSSS Finance Committee. And if this wasn't enough, he has now accepted to be the Foundation's Treasurer!

Ronny is a great example of the adage "if you want a job done right, give it to a busy man." We are fortunate indeed to have him in our ranks.

Pierre Brosseau and Ronny Steinberg are truly wonderful role models of what informed and committed volunteers can be and can accomplish for the benefit of the Hospital, its patients and the entire community. Congratulations!

In MemoriamLawrence Yanofsky Z"L

(1925-2018)

Lawrence Yanofsky's love for theJewish General Hospital was manifested by

being a major donor and supporter throughout the Hospital, including, among others, the

Memory Clinic, Cardiology, Urology, Colorectal Surgery, Pathology and Infection Control.

Lawrence and his life partner Verley lived life fully, celebrating their profound commitment

to each other and their family.

The entire JGH family extends sincerecondolences to Verley, Rhona and Irwin Kramer,

Peter and Franki, and David.

Ronny Steinberg receives the Foundation Outstanding ServiceAward from JGH Foundation Chair Edward Wiltzer.

Who We Are…

Mission Statement


Our mission is to advance health care and medical research for the people of Quebec by supporting Montreal’s Jewish General Hospital, a tertiary-care, McGill University teaching hospital.

The Foundation provides essential assistance to the hospital to enhance its extraordinary patient care, to further scientific discovery and to acquire the most recent and innovative medical equipment.

We partner with inspired members of the community to implement a wide variety of fundraising initiatives to achieve these ambitious goals.

ValuesFOCUS AND DIRECTIONWe are clearly aligned with our goals and united in the pursuit of our mandates. We share a sense of common purpose and priorities with our stakeholders.

INTEGRITYWe are committed to performing our activities with respect and transparency. All board members, management, staff and volunteers meet the highest standards of personal and professional integrity.

OPENNESSWe encourage new ideas and feedback, and we respect differences with a spirit of inquiry and sensitivity. We work in an open environment where we continuously seek to understand the needs, interests and opinions of others.

TRUST AND MUTUAL RESPECTWe are guided by mutual respect in interactions with our staff, board members, donors and volunteers, and are committed to building long-term relationships based on trust and fairness.

RESPONSIBILITY AND ACCOUNTABILITYWe are dedicated to being fiscally responsible with the funds entrusted to us by our donors, and we are accountable to our stakeholders.

Since 1969, the Jewish General Hospital Foundation has conducted a

dynamic fundraising program in support of the Jewish General Hospital (JGH),

a 637-bed McGill University teaching hospital renowned for the excellence of its

healthcare services and the calibre of its medical and research staff. As one of

Quebec’s leading acute-care hospitals, providing general and specialized

care to a diverse patient population, the JGH plays a vital role in the Quebec

healthcare system. Thanks to a productive partnership between our dedicated

staff and passionate volunteers, the hospital and its patients have benefited

greatly from the Foundation’s many fundraising initiatives.


POWERTO HEALCAMPAIGN PROGRESS REPORT

In 2016-2017, the JGH Foundation’s “Power to Heal”

campaign—its most ambitious Capital Campaign to date,

with a goal in excess of $250 million—continued to

progress. We are proud and gratified to report that over

$217 million in pledges and direct gifts has been raised

as of March 31, 2017—now approaching $250 million as

this publication goes to press. This growth is obviously the

result of the generous spirit of our donors and the dedication

of our leaders: Campaign Co-Chairs Harvey Levenson,

Christine Marchildon and Bernard Stotland, FCPA, FCA,

our devoted Vice-Chairs Ralph Benatar, Gaby Bitton,

André Bureau, O.C., Q.C., Jean Bureau, Pierre Brosseau,

André Charron, Vincenzo Guzzo and Pierre Meloche, O.C.;

Senior Advisor Edward Wiltzer; and Honourary Chairs

France Chrétien Desmarais, C.M., the Honourable

E. Leo Kolber, O.C., and Michael Sabia.

The campaign has had a profound impact on the JGH’s

ability to provide outstanding, quality medical care to our

population. This has been manifested in so many ways, be it

the best and latest equipment, the renovation of facilities,

support for research and most importantly, the recruitment

of physicians, clinician scientists, nurses and allied health

professionals. In the following pages please note how every

dollar donated to the "Power to Heal" campaign makes an

important difference for our patients.

Our Capital Campaign theme,

You have the Power to Heal, expresses

the very essence and core of what the JGH

and its supporters are all about.

It sums up in a few words our common

goal of achieving better health and better

health care for the people of Montreal and

Quebec, now and in the future.

It represents the fact that each of us is a

stakeholder and plays an important role

when it comes to ensuring the continued

health and well-being of those we love and,

indeed, the entire community.

It stands for the power that each one

of us has to make a difference and what

can be accomplished when our hospital’s

leaders, medical staff and generous donors

come together for a common purpose.

YOU HAVE THE POWER TO HEALCONTRIBUTE


Bringing the best and brightestdoctors and researchers to Montrealand Quebec, and supportingtheir workDr. François Mercier joined the JGH Division of Hematology as an attending physician and clinician scientist, and the Lady Davis Institute (LDI) as a principal investigator in blood cancers in early 2017. After finishing his training in hematol-ogy at the JGH and McGill University as Hematology Chief Resident, he spent the past seven years on a research fellowship at Harvard University and Massachusetts General Hospital where he worked on understanding how blood stem cells regenerate and mutate to form leukemias. His specific area of interest is acute myeloid leukemia (AML). At the LDI, Dr. Mercier will pursue a clinical study to employ single cell RNA sequencing on cell samples taken

from patients with AML in order to distinguish between the cells of those patients who respond favourably to certain drug therapies as opposed to those who do not. As well, he is employing the revolutionary gene editing technology CRISPR to see whether splicing genes associ-ated with AML can eliminate the disease. Dr. Mercier will also be performing clinical duties and teaching in outpa-tient and inpatient care in clinical hematology, as well as clinical research in collaboration with Dr. Sarit Assouline, a leader in clinical trials in malignant hematology based at the Segal Cancer Centre.

expanded CRU is also in a better position to support the Eileen & Louis Dubrovsky Molecular Pathology and Microbiology Centre in achiev-ing the full molecular characteriza-tion of a tumour, the main challenge in developing targeted therapies.

New bedside terminals linked to a modified Endovault Oncology platform with added functionalities are allowing all caregivers at the Segal Cancer Centre to generate electronic notes, order tests, order and document chemotherapy administration in real time, manage chemotherapy treatments and share vital patient information with the rest of the medical team at the JGH. Having access to a complete electronic record of a patient at the bedside saves time, enhances the quality and accessibility of vital patient information, increases clinical efficiency and helps prevent costly errors, resulting in improved coordination and continuity of care, and safety for the patients. The new bedside terminals are also designed to be used for patient education and allow patients to make calls and watch TV during the time of treatment.


Providing the finest facilities, equipmentand programs to deliver excellence andmeet the changing healthcare needsof Quebecers

Located in the space that used to house the Emergency Department in Pavilion D, the fully renovated and computerized Sandra & Steven Mintz Nephrology Centre is enabling Dr. Mark Lipman and his team to ensure the provision of life-saving treatments to the grow-ing number of patients with kidney failure. It contains 37 spacious hemodialysis stations with enhanced privacy, each of which includes a hemodialysis machine, a multi-function chair, internet access for a personal computer or tablet, and a bedside terminal that provides patients with secure, touchscreen access to free basic TV and internet services as well as to numerous premium entertainment options. With its up-to-date isolation areas, upgraded water filtration system, dedicated pick-up and drop-off area and family meeting rooms, the Centre provides patients, who must come to the hospital three times per week to receive a treatment that usually requires four hours, with the safe, comfortable and emotionally supportive environment that is

conducive to a superior quality of care and patient experience. The Centre also features a state-of-the-art video conference room for teaching and education. It is used to provide specialized training that focuses on the complex technology involved, as well as the psychosocial component of helping patients and their families adjust to dialysis treatment.

The newly upgraded Maria Saputo Monticciolo Clinical Research Unit (CRU) at the Segal Cancer Centre enables more cancer patients to have access to new, cutting-edge treatments and drugs via participa-tion in clinical trials. This process is critical for gathering the data necessary to determine those conditions under which the drugs will prove most effective and to offer better outcomes to patients for whom more conventional treat-ments have run their course. In addition to providing more support to other JGH clinical trials, the

The newly renovated and expanded 6,000-square-foot Pathology Laboratory, on the first floor of Pavilion G, is enabling the JGH Department of Pathology to rapidly perform a higher volume of vital diagnostic evaluations of tissue samples. With more space, improved mechanical systems and the addition of a high-performance Laboratory Information System, the upgraded laboratory provides clinicians with the reliable results they need to more quickly establish accurate diagnoses and appropriate treatment plans. It also is enhancing the availability of information that is essential to monitor-ing and preventing disease, as well as assisting with research throughout the hospital. Considering that about 60 percent of clinical decisions in a hospital are based on results provided by the Pathology Division, especially in the area of cancer, the new Pathology Laboratory is an indispensable partner of the Segal Cancer Centre and plays a central role at the JGH in improving the quality and extending the lifespan of a growing number of cancer patients.

Acquisition of an infection control and antimicrobial stewardship integrated system for the Infectious Diseases Clinic. This state-of-the-art software technology allows for real time surveillance and reporting on hospital-acquired infections as well as ensuring a permanent watch on antimicrobial prescriptions and laboratory orders. It constitutes an invaluable tool for reducing the incidence and prevalence of infec-tions and facing the challenge of overconsumption and growing resistance to antibiotics, ultimately resulting in improved patient care and safety. The system will also facilitate rapid intervention in case of an outbreak and reinforce the hospital’s collaboration with the CHUM and CUSM, which are both using the same technologies.

Upgrade of Chartmaxx, the fully computerized and digitized patient record system which is used to track patient test results and chart all care activities across the hospi-tal. By providing quick, online, intuitive 24/7 access to critical patient information to physicians and staff, the upgraded system allows for better communication and coordination between all hospital departments, improving overall efficiency and workflow, resulting in shorter waiting times and enhanced patient care.

Acquisition of a digital Direct Visualization System for the Division of Gastroenterology. This innovative technology provides direct visual access via an endoscope to the bile ducts and pancreas, helping to obtain an accurate diagnosis and deliver effective treatment options for diseases and conditions such as gallstones and suspected malignan-cies, including pancreatic cancer, in one procedure. Direct visualization of the biliary tree also provides important information that cannot be obtained by other diagnostic modalities such as an abdominal ultrasound, a CT scan, or a MRI. Moreover, the system can be used to obtain biopsy specimens, destroy hardened masses like kidney stones and gallstones, and perform proce-dures involving irrigation and suction of the biliary tract and pancreatic ducts in an easier and more effective way.


A new, dedicated portable ultrasound machine is allowing the team of Internal Medicine specialists at the new Diagnostic and Treatment Clinic (DTC) within the Medical Day Hospital in Pavilion K to deliver rapid, accurate and patient-centered expert clinical care at the bedside. This advanced ultrasound machine enables physicians to diagnose why a patient is short of breath or having chest pain or abdominal pain without having to wait weeks or months for dedicated radiology studies, and to perform invasive interventions to confirm a diagnosis and provide therapy, all during the same visit without unnecessary delays. As a result, the DTC stands out as a much better alternative for ambulatory patients who need expedited care (imaging, minor procedures, etc.) and who might otherwise end up being admitted through the Emergency Department.

Ongoing support for the Peter Brojde Lung Cancer Centre is strengthening the patient-centred facility's ability to provide the growing number of lung cancer patients being treated at the JGH with all of the services they need in a single, dedicated location. The Centre is dedicated to holistic and personalized patient care that enhances treatment efficacy and the quality of life of patients with lung cancer, and their families, by com-bining the best that conventional medicine and modern science has to offer with practices relating to diet, yoga, exercise, Ti Ji , psycho/social counselling and therapies foundin Traditional Chinese Medicine. Working in conjunction with clinical departments throughout the Segal Cancer Centre and JGH, the Centre provides a comprehensive, coordi-nated approach to care that seeks to detect tumours earlier and stage them more accurately, provide better and more targeted treat-ments, and integrate traditional Chinese medicine into standard treatments. Special programs are also devoted to family membersand caregivers. The Centre also promotes prevention strategies to reduce lung cancer incidence and conducts cutting-edge research in experimental therapeutics to improve outcomes and quality of life for all patients with lung cancer, especially those with advanced disease undergoing treatment.

Acquisition of two handheld, portable diagnostic Spirometers with disposable mouthpieces for the Department of Respiratory Physiology. These devices are specifically designed to measure a range of respiratory parameters and to monitor the saturation of oxygen in the blood and the heart beat. They play a vital role in the diagnosis of certain types of lung disease, such as asthma, bronchitis, and emphysema; finding the cause of shortness of breath; assessing the effect of contaminants as well as of medication on lung function and measuring progress in disease treatment.

Inauguration of the Department of Psychiatry’s Mental Health Education Centre, comprising 5 offices (9 work spaces) designed for trainees to safely evaluate and treat patients, and 2 teaching/conference rooms connected by a two-way mirror to allow staff to directly observe residents interviewing patients and then provide them with constructive feedback. These rooms are also equipped with state-of-the-art audiovisual technology for deliver-ing lectures to the various trainees. The Centre will allow the Depart-ment of Psychiatry to accept a greater number of trainees in the fields of psychiatry, family medicine, nursing, psychology, occupational therapy and social work, over and beyond the more than 200 trainees from various CEGEPs and universi-ties already participating in its educational program.


proving invaluable for the speedy diagnosis and management of patients who come to the ER for bladder-related conditions. Two adapted mobile carts were also acquired to facilitate the use of the device at the bedside throughout the Emergency Department.

Acquisition of an intramuscular lead (thin wires) and a neurostimulator along with accessories for the Division of Colorectal Surgery’s Sacral Nerve Stimulation (SNS) Program. SNS involves the implanta-tion of a permanent neurostimulator that provides patients suffering from severe fecal incontinence with a means to control the involuntary loss of solid or liquid stool, helping them live a fairly normal life again. The leading-edge, minimally inva-sive procedure has excellent success rates, minimal complication rates, and sustained long-term positive outcomes with a dramatic impact on quality of life.

Continued support of the Youth Mental health Coordinator part-time position at the Department of Psychiatry. This Coordinator is responsible for facilitating referrals and providing liaison services to the community, and plays an essential role in reducing the number of youth on the waiting list for psychiatric screening, assessing more youthper week and providing ongoing therapy to more youth whose level of distress and dysfunction is too severe for first line services. Other improvements include: the launchof the Aminy online portal where patients can access information and communicate with their therapists in an accessible, patient centered format; and the conversion of the Department of Psychiatry’s paper medical records to a digital format, allowing for the sharing and use of patient information by other hospital departments. With electronic medi-cal records, patient care and safety is improved by avoiding duplication, speeding up decision-making, reducing the potential for lost information or decisions made on erroneous or incomplete informa-tion, and providing a greater means to collect and report on the clinical outcome measures that are used to monitor, evaluate and improve the quality of care. Monthly reward / recognition luncheons for kids at the Centre for Child Development and Mental Health were also made possible thanks to a generous donor.

Karine Choquet, a PhD candidate in human genetics at McGill University supervised by Dr. Claudia Kleinman from the Lady Davis Institute (LDI), was named the recipient of the

3rd Annual National Bank Excellence in Research Award. This award has been established by the National Bank to advance medical research in the area of molecular pathology as part of a longstanding commit-ment to the Jewish General Hospital (JGH). Karine Choquet works in the crucial domain of bioinformatics applied to neurodevelopment and neurodegenerative diseases, such as leukodystrophies which affect one in 7,000 children and remain incur-able. The National Bank Molecular Pathology bursary will help set a momentum for increased collabora-tions between bioinformaticians at the LDI, other researchers, and financial informaticians working with large datasets.

A new, portable intraoral camera used in conjunction with a state-of-the-art intraoral digital sensor and image management system is allowing the Department of Dentistry to take digital diagnostics as well as patient education and documenta-tion to the next level. Combining the latest digital technology with full motion video and dynamic image management, the system provides an easy way to illustrate, communi-cate and document what is goingon in the patient's mouth, whetherit is a fractured tooth, restoration,or periodontal issue. As such, it is greatly improving the diagnostic process and the whole patient experience.

A new, portable 3D ultrasound designed to measure urinary blad-der volume is helping Emergency Department physicians to assess urinary retention and evaluate many common urological problems quickly, accurately, and noninva-sively. This specialised ultrasound is


Establishment of the Dr. Andréa Joy Cohen Fellowship for Esophageal and Gastrointestinal Cancer. Under the supervision of medical oncolo-gist Dr. Petr Kavan, Director of the Adolescent and Young Adult Cancer Program, this Fellowship provides support to recruit and train one fellow annually. This fellow will be responsible for improving the quality of life in patients diagnosed with esophageal-gastrointestinal cancer by focusing on new treat-ments, patient care and treatment experiences. Ultimately, the goal will be to establish an endowment fund to support the Fellowship in the mid- and long term.

A new lower body trainer device, with hydraulic height and knee bending adjustment as well as thumb wheel leg guides with adjustable knee protection and expandable chassis, is contributing to improving the overall well-being and reducing the length of stay of bed-ridden patients in the Azrieli Medical and Surgical Intensive Care Unit (AMSICU). Easily adaptable to a nursing bed or therapy chair, the device helps maintain body functions, improve blood flow, digestion and motor functions, regulate muscle tone and stabilize the circulation—contributing to increase the healing process and prevent secondary diseases for patients who are bed-ridden in the AMSICU as a result of accidents or surgeries.

A new tissue aligning device made specifically for Mohs procedures is enabling the Miriam and Sydney Pinchuk Dermatology/Oncology Centre to minimize tissue waste and remove as little skin as possible in the process of excising a skin cancer. It eliminates errors in tissue preparation and allows the physi-cian to obtain the true surgical margin with minimal false positives, thus averting the need for further surgery as well as poor cosmetic outcomes for patients.

Acquisition of a radiology information system with a specialised obstetrics-gynecology module, an appointment module and a report management interface for the Department of Obstetrics and Gynecology. This software allows for the acquisition, distribution and archiving of medical images, such as ultrasound findings, and diagnostic reports across the hospital, providing access to informa-tion when and where it is needed which is crucial to optimal patient care.

Fifteen new hydraulic transport stretchers, equipped with a retractable fifth wheel and integrated oxygen bottle holder, are helping the JGH Transport Department to move patients throughout the hospital more efficiently and safely than transporting them in standard beds, without incurring the kind of effort and strain that can lead to injury.

Support of a Patient Care Coordinator for patients with gastrointestinal malignancies and for the Adolescent and Young Adult (AYA) Oncology program. The Coordinator helps patients navigate the complex health care system, coordinating their care and supporting them throughout the course of their illness to ensure the best qualityof care and patient experience possible.


microdebrider

surgical power console

endoscope lenscleaning sheath

Acquisition of a new microdebrider powered by a multispecialty surgical power console along with 2 endoscope lens cleaning sheaths for theDepartment of Otolaryngology — Head and Neck Surgery. The innovative microdebrider lets the surgeon rotate only the tip of the curved blade during Ear Nose Throat (ENT) surgery, enabling 360-degree cutting in the frontal sinuses, a more complete removal of polyps and mucin in the maxillary sinuses, and greater access to target tissue in the lateral and posterior areas of the airway. As a result, ENT surgeons can perform a more precise, complete removal of obstructive or diseased tissue. For their part, the software-driven lens cleaning sheaths are accessories that can deliver a high-power burst of irrigation to flush debris out of the endoscope lens tip, helping surgeons maintain maximum visualization at the surgical site and significantly improving the ability to operate in the presence of bleeding during nasal and sinus endoscopic surgery.

Ongoing support for the establish-ment of an endowment fund to provide a stable source of funding for the Orthopedic Surgery Fellowships and Research Program, which allows for the recruitment of two fellows annually in addition to supporting research at the Orthopedics Research Laboratory in the Lady Davis Institute at the JGH. The creation of this endowment fund is crucial to enable the Departmentof Orthopedics to meet the rising demand for accessible, life-enhancing treatment and care, and to maintain its leadership and expertise in orthopedic surgery, research and teaching.


The purchase of specialized (state-of-the-art medication distribution machines and refrigerators for medications and food, a bariatric commode and wheelchair, a second patient lift) and basic equipment (portable hampers for the isolation gowns, two racks for food trays, a second high tech printer, a second blood sampling cart, and an extra medication cart) has made it possible for the staff of the two nursing units on the 7th floor of Pavilions C and D to transition smoothly to the new, larger and more modern CD7 Medicine Nursing Unit. The acquisition of this basic but much needed equipment allows the Nursing Unit to continue to provide the best and most compassionate

care possible to patients who suffer from various conditions that are not serious enough to warrant admission but must be closely monitored and treated. Fully 75% of patients are over 75 years old with complex medical needs. Many are highly vulnerable people with social problems, no support at home,and who have nowhere else to go.

Support for the McPeak/Sirois clinical trials in breast cancer.The goal of this project, shared by the four major Quebec hospital research centres (JGH, CHUM, MUHC, CHU du Quebec), is to improve care given to patients suffering from breast cancer through better access to clinical trials. Two unique clinical trials were launched in October 2016, one on molecular changes occur-ring when taking a new medication and the other on a diagnostic test designed to help physicians deter-mine if a medication should be taken before or after surgery.

Inauguration of the Azrieli Medical and Surgical Intensive Care Unit located on the third floor of Pavilion K, initiating a new standard of care for critically ill patients or those who have just had major surgery, both of whom need constant monitoring and care from a specialized team.

“If it wasn't for thoughtful donors like you, we simply would not be able to continue to provide our patients with the attention and

quality of care they deserve. The pieces of equipment that were

acquired for our unit don't seem like much and don't cost a lot, but they make a world of difference for our patients and staff. Thank you!”

-Josina Van Den NieuwenhofCD7 Medicine Nursing Unit Head Nurse

A new tissue aligning device made specifically for Mohs procedures is enabling the Miriam and Sydney Pinchuk Dermatology/Oncology Centre to minimize tissue waste and remove as little skin as possible in the process of excising a skin cancer. It eliminates errors in tissue preparation and allows the physi-cian to obtain the true surgical margin with minimal false positives, thus averting the need for further surgery as well as poor cosmetic outcomes for patients.

Acquisition of a radiology information system with a specialised obstetrics-gynecology module, an appointment module and a report management interface for the Department of Obstetrics and Gynecology. This software allows for the acquisition, distribution and archiving of medical images, such as ultrasound findings, and diagnostic reports across the hospital, providing access to informa-tion when and where it is needed which is crucial to optimal patient care.

Fifteen new hydraulic transport stretchers, equipped with a retractable fifth wheel and integrated oxygen bottle holder, are helping the JGH Transport Department to move patients throughout the hospital more efficiently and safely than transporting them in standard beds, without incurring the kind of effort and strain that can lead to injury.

Support of a Patient Care Coordinator for patients with gastrointestinal malignancies and for the Adolescent and Young Adult (AYA) Oncology program. The Coordinator helps patients navigate the complex health care system, coordinating their care and supporting them throughout the course of their illness to ensure the best qualityof care and patient experience possible.


Ongoing support for the Nursing Education and ProfessionalDevelopment initiative, which provides funds to sponsor, in whol or in part, educational and networking opportunities that empower JGH nurses to rise to the top of their field. In this way, they can excel at deliver-ing superior care in a humane and compassionate manner. The initiative has made possible such activities as participation in the Canadian Nursing Association specialty certification program, pursuit of Master’s degree studies, attendance at prestigious regional, national or international conferences and other continuing education events, Nursing Week 2016 activities, the Department of Nursing’s Annual Symposium, which had for theme this year Mind the Nursing Gap: The Complexities of Nursing Staff Mix and Care Delivery, Clinical Nurse Education Day, the ICU Family Rounds, and support for research in nursing development.

Ongoing support of an Endowment Fund for the Centre of Excellence in Spinal Surgery, within the Division of Neurosurgery. This fund is designedto provide a permanent and stable source of funding to support the Centre’s operations, the training of one Fellow per year in minimally invasive and complex spinal surgery, and empower it to continue to provide patients with the benefits accruing from the latest technologies.

The 2017 LDI / TD Bank Scholarships supported the research efforts of Master and PhD students Alexis Blanchet-Cohen (breast cancer), Marisa Cressatti (Parkinson’s disease), Emma Fowler (breast cancer),Yi Lian (prostate cancer), Sahil Sharma (molecular oncology),and Yimeng Wang (HIV).

Ongoing support for the JGH Azrieli/Israel Fellowship program, which provides vital funding to recruit and train talented Israeli medical practitioners and research-ers each year. In 2016-17, these included: Dr. Gil Shechtor-Maor who completed a 2-year fellowship in High Risk Pregnancy, Dr. Gabriel Gutman, who is in his second year of a 2-year fellowship in Spinal Surgery, and Dr. Efrat Spiegel, who is completing a 1-year fellowship in Maternal/Fetal Medicine. All three physicians will apply the expertise that they have gained from their Fellowship training in their respec-tive home cities, often becoming the key experts at the local or even national level.

Ongoing support for the Goldman Herzl Family Practice Centre’s Continual Improvement Fund, which is used to improve the quality of care through new healthcare programs, staff training and organi-zational enhancements; for the

Vicki & Stan Zack and Family Herzl Teenage Health Unit (THU), which provides free services ranging from basic medical care and reproduc-tive health to helping teens aged 13 to 19 deal with problems such as bullying, depression, stress, anxiety, substance abuse, eating disorders and suicide; and for the Goldfarb Breastfeeding Clinic, which provides breastfeeding families with lactation services based on excellence of care and current research, educates professionals in lactation manage-ment, and contributes to the field of breastfeeding research, all within an inter-disciplinary setting. In addi-tion, a generous donor covered the cost of a cycle of weekly therapy sessions for a troubled teenager treated at the THU for a full year.

Ongoing support for innovative programs that cater to the special needs of particular groups of cancer patients and are funded in part through private donations. These include the Adolescent and Young Adult (AYA) Oncology Program, the Cancer Nutrition-Rehabilitation Program (CNRP) and the Cancer Prevention Centre.

Ongoing support through the Urachal Cancer Research Fund for the world’s first DNA screening research project focused on cancer of the urachus (a small tube that runs behind the belly button that normally shrivels away after birth), an extremely rare form of cancer that accounts for only 0.2% of all bladder cancers. The project teamis led by Dr. Normand Blais, an oncologist at Hôpital Notre-Dame, with an advisory board that includesDrs. Franck Bladou, Chief of the JGH Division of Urology and Gerald Batist, Director of the Segal Cancer Centre, and Dr. Andrew Steinberg from Hôpital Charles-Lemoyne, with the ultimate goal of finding better treatments and a cure for urachal cancer.

SinskeyLens Hook

Capsulorhexisforceps

Phacochoppers

Ongoing support for the JGH Hope & Cope Cancer Wellness Centre (Lou’s House), recognized nationally and internationally as a leader in psychosocial support for cancer patients and which is entirely funded through private donations. Hope & Cope is a unique community organi-zation that provides cancer patients and their loved ones with a wide range of patient education and psychosocial support programs and services that are designed to help them cope with the stress of cancer at all stages of the disease. The Wellness Centre offers complemen-tary and expressive therapies such as yoga, qi gong, art and choir, coping skills training and self-help groups and is the only centre of its kind in Canada with a research program that contributes to the growing body of literature on the impact that wellness programs and psychosocial support have on quality of life and survivor-ship. All services are free of charge, offered in English and French, and open to all patients regardless of hospital affiliation.

Support for the ongoing operation of the JGH/McGill Memory Clinic and its Marjorie & Gerald Bronfman Memory Evaluation Unit. The Memory Clinic—the largest of its kind in Canada—, which is funded in part by private donations, provides unparalleled expertise in the early diagnosis and treatment of memory disorders and dementia. As a major centre for the recruitment of memory-impaired or Alzheimer’s disease subjects into studies of new therapies, it plays a vital role in making possible clinical trials that enable patients to have access to new, cutting-edge treatments and drugs before they become widely available.

Ongoing development of the Insulin Pump and Diabetes Education Centre, the first of its kind in Quebec, which provides the growing number of patients suffering from diabetes with the comprehensive care and support they need to achieve and maintain optimum control of their disease.


Ongoing support for the Hospital Elder Life Program (HELP) at the JGH. This is an innovative program, which uses carefully trained volun-teers to provide targeted therapeu-tic interventions at the bedside for hospitalized older patients. The program is designed to assist hospital staff in improving geriatric care and, more specifically, to minimize delirium and functional decline in elderly patients during hospitalization. Its goals are to preserve cognitive and physical function, decrease the length of stay and the use of psychoactive medications, and avoid long-term care placement for this patient population. Implemented in more than 200 sites worldwide, HELP was shown to improve the overall quality of hospital care for elderly patients as well as outcomes, because patients who maintain or improve their cognition are more capable or apt to adhere to their plan of care.

Support for a clinical trial managed by the Maria Saputo Monticciolo Clinical Research Unit (CRU) targeting a cellular factor, eIF4E, which is involved in making cells cancerous, in combination with resistance to ribavirin, a novel therapy in the treatment of M4/M5 acute myeloid (AML) leukemia patients that suppresses eIF4E.

the Centre to become an academic center of excellence providing patient-centered care and employ-ing best practice standards and outcome research methods for patients undergoing uncomplicated cataract surgery requiring no local or general anesthesia. Specialized instruments, such as capsulorhexis forceps, Phaco choppers, lens hooks, capsular retractors, a fixation ring and knife trays, that are critical in performing modern cataract surgery, were also acquired.

Launch of the Thomas Hecht Academic Cataract Centre by the Department of Ophthalmology.This new area, dedicated to cataract surgery and located on the third floor of Pavilion G, focuses on the patient experience, and on quality and clinical research in order to improve outcomes. It features extra seating in the waiting room and in the recovery area for family mem-bers as well as new locker rooms, a lounge and a research room with big, bright windows for the benefit of the staff. The ultimate goal is for


Creation of the Nathan and Nettie Yentin Endowment Fund for Hospital Priorities which serves as a general endowment for the JGH, ensuring a stable, recurrent source of funding for vital patient programs and special equipment for which there is no regular funding source. An endowment fund is one where the capital is invested in perpetuity and managed by an investment commit-tee of the JGH Foundation. The interest from the fund is distributed annually based on a specific designa-tion of the donor or to hospital priorities defined by the Hospital and the Foundation. Thus, the endow-ment ensures a flow of funding, year after year, and makes long-term planning, financial stability and successful functioning possible. Such an endowment is critical to the future of the hospital and its ability to continue to deliver excellence in patient care, research and teaching that will benefit Montrealers and Quebecers for generations to come.

Hospital-grade furniture and basic equipment for patient care (such as chairs, carts, IV poles, trays, elec-tronic thermometers, tables and sofas, storage cabinets, television sets, specialized refrigerators, and keypad controllers) for various nursing stations and staff lounges, patient care units, waiting rooms and family rooms throughout the hospi-tal. They have contributed to enhancing the comfort and safety of patients and staff.

Ongoing support for a feasibility / safety study of Intraoperative Radiation Therapy (IORT) for the treatment of early-stage breast cancers, being conducted by the Division of Radio-Oncology. IORT allows for the delivery of the entire course of radiation treatment to the patient at the time of surgery, with great precision to the desired location in only a few minutes, thereby reducing treatment time from the standard 3 to 6 weeks to a single exposure. It also offers very good dose homogeneity and reduces exposure of normal tissues (for instance, lungs, heart and skin) to radiations. IORT is powered by advanced brachytherapy technol-ogy that can be configured and adapted to treat cancer anywhere in the body, including gynecological cancers, eye cancers and non-melanoma skin cancer. To date, Dr. Te Vuong and her team have successfully treated 7 patients with early-stage breast cancer and one patient with skin cancer using this new radiotherapy technique, as well as 20 patients with colorectal cancer through the development of a specially designed applicator. The JGH expects to treat about 60 patients per year with IORT and will be the first in Canada to offer access to this unique and practical treatment that greatly improves patient care and quality of life.

Support for the Beth Raby Adult Congenital Heart Disease Clinic, which provides expert care to young adults who were born with heart defects.

Ongoing support for the Family Caregiver Support Centre and its programs at the Marjorie and Gerald Bronfman Division of Palliative Care. The Centre provides caregivers with access to informa-tion, training, resources and support services that empower them to meet the challenges of caring for a loved one in the final stages of their life at home and improve their quality of life. It also promotes a more supportive environment for home caregivers through research, advocacy and education. The Centre and its programs play a vital role in easing the growing burden and stress of family caregivers and ensuring the comfort and dignity of people living with a terminal illness in our community and beyond.

Support for the Teaching and Simulation Centre of the Emergency Department, which uses medical simulation to enhance the skills of ER physicians and staff, and to improve patient safety and quality of care through education, research, evaluation and innovation.

Digitization of the geriatric Self-Administered Questionnaire (SAQ) to make it more readily accessible to the general population. Devel-oped by the RUIS McGill Centre of Excellence on Longevity based at the JGH, this questionnaire is the first scientifically validated health and functional status self-assessment tool for the elderly. It is designed to help predict deleterious health events and target elderly people at risk earlier, so that effective preventative measures can be put in place to preserve their health and qualityof life.


Support for the Cardiovascular Prevention Centre and its unique, integrated approach to diagnosis, treatment and research of high risk cardiovascular conditions that enables patients to consult several specialists and allied health profes-sionals in one visit, considerably improving the whole process of patient care. The Centre’s staff advises patients with high blood pressure, high cholesterol, diabetes, or those who are obese or smokers, and most often several of these in combination, on how to prevent cardiovascular disease or more easily cope with the symptoms of an existing condition.

Ongoing support for the Ludmer Centre for Neuroinformatics and Mental Health. This initiative will harness basic and clinical research at the Douglas Institute, McGill University, the Lady Davis Institute at the JGH, the Montreal Neurological Institute and Hospital, the JGH and other international bodies, enabling the creation of a global hub for the study of human development and mental health. The Centre will use an innovative and unprecedented multidisciplinary approach that incorporates such areas as neurosci-ence, computational biology, math-ematics, genetics, epigenetics, bioinformatics, epidemiology and computer science. It will also analyze and process complex amounts of data from research projects around the world, with the ultimate goal of significantly reducing the rate of mental illness by identifying scien-tific methods to establish early childhood risk factors.

With generous ongoing support,the Centre of Excellence inGeriatric Psychiatry has recruited Dr. Soham Rej, a clinical-scientist specializing in Psychogeriatric research, and Allana Goodman, an Occupational Therapist, who specializes in treatment develop-ment and the assessment and intervention of at risk drivers. The Centre aims to meet the growing demand for evaluation, diagnosis and treatment of the elderly suffer-ing from mental health problems such as depression, anxiety disor-ders, psychotic disorders and cognitive impairment. The plan is to establish a comprehensive outpa-tient Psychogeriatric Treatment Program based on the current best practices, to develop and validate innovative treatment interventions, to provide an environment for the development of knowledge and the academic training of all profession-als involved in the mental health care of the elderly. The Centre aims to become an international leader in the research of late-life psychiatric disorders, with multiple ongoing innovative clinical trials and other research projects.

Ongoing support for a landmark clinical trial of a novel combination treatment for type 1 diabetes, being conducted jointly by investigators at the Lady Davis Institute of the JGH and at the McGill University Health Centre (MUHC). Based largely on pioneering research by Dr. Lawrence Rosenberg, President and CEO of West‐Central Montreal Health and Executive Director of the JGH, the treatment combines a

specific agent to restore normal insulin secretion in the pancreas with a drug to prevent the autoimmune system from rejecting the newly formed insulin secreting islets to treat patients with longstanding type 1 diabetes. Type 1 diabetes develops when the body's immune system destroys the beta cells that make insulin within the pancreatic islets and affected people require insulin therapy to survive. The ground-breaking study is an important step towards finding, for the first time ever, an effective therapy for this chronic disease that often begins in childhood and affects over 1.5 million people in North America.

A new integrated proteogenomics platform, comprising two state-of-the-art mass spectrometry instruments and a Cloud Connect software license, is enabling the McGill/JGH Proteomics Centre in the Eileen and Louis Dubrovsky Molecular Pathol-ogy and Microbiology Centre to bring genomic and proteomic data, and analysis tools, together in a cloud computing environment to facilitate alignment, data storage, bioinformatics data processing, and the discovery of biomarkers. The platform also enables researchers to share results instantly and collabo-rate with other investigators world-wide. Dr. Rene Zahedi, a renowned expert in phosphoproteomics, was also recruited as the Group Leader of the Warren Y. Soper Charitable Trust McGill Translational Proteomics Program at the Proteomics Centre. The JGH now has a fully functional and well-staffed state-of-the-art proteomics facility, which is currently equipped with 5 mass spectrometers, and 6 people, including 2 graduate students from McGill. (for more information on proteomics, please see page 21)

Ongoing support for a feasibility / safety study of Intraoperative Radiation Therapy (IORT) for the treatment of early-stage breast cancers, being conducted by the Division of Radio-Oncology. IORT allows for the delivery of the entire course of radiation treatment to the patient at the time of surgery, with great precision to the desired location in only a few minutes, thereby reducing treatment time from the standard 3 to 6 weeks to a single exposure. It also offers very good dose homogeneity and reduces exposure of normal tissues (for instance, lungs, heart and skin) to radiations. IORT is powered by advanced brachytherapy technol-ogy that can be configured and adapted to treat cancer anywhere in the body, including gynecological cancers, eye cancers and non-melanoma skin cancer. To date, Dr. Te Vuong and her team have successfully treated 7 patients with early-stage breast cancer and one patient with skin cancer using this new radiotherapy technique, as well as 20 patients with colorectal cancer through the development of a specially designed applicator. The JGH expects to treat about 60 patients per year with IORT and will be the first in Canada to offer access to this unique and practical treatment that greatly improves patient care and quality of life.

Support for the Beth Raby Adult Congenital Heart Disease Clinic, which provides expert care to young adults who were born with heart defects.


New walking jackets for the Department of Physiotherapy’s weight-support system are being used for patients with conditions causing profound sensorimotor deficits, who cannot walk or put weight on their legs. These jackets now make it possible to start the rehabilitation process much earlier and in a more controlled and secure environment. They enable a physio-therapist to assist patients of any height or weight to stand and practice walking without risking injury. Patients benefit greatly from starting rehabilitation early and gaining confidence in themselves, and in the process, enhancing their recovery.

Support of the 12th Annual Department of Psychiatry Gustav Levinschi Research Day at the Lady Davis Institute—an annual event held for the public in which internationally recognized work that is taking place in the Department is featured. This year’s Research Day was held on March 10, 2017 and had for title THERE SHOULD BE AN APP FOR THAT: The Promise of Technology for Mental Health. It featured topics such as what patients want to know when navigating the online health universe, participatory E-health, understanding the radicalization of youth, the effects of war and trauma, and harvesting the wealth of informa-tion from daily life.

Acquisition of doses of a specialized radioisotope ligand that is injected as part of a new diagnostic imaging technique called PSMA PET/CT. This Nuclear Medicine imaging modality allows for the detection of prostate cancer cells anywhere in the body more accurately than with tradi-tional methods, while also avoiding false-positive results. It offers the level of sensitivity and specificity required to detect and visualize metastatic prostate cancer in newly diagnosed high-risk prostate cancer patients and in those with recurrent prostate cancer, allowing doctors to make better-informed treatment decisions which lead to better outcomes for these patients.

Support for the Harvey H. Sigman Lecture in Surgical Education, an annual lecture series established in recognition of Dr. Sigman’s lifelong commitment to education to enhance the Surgical Education Program at the JGH and McGill University. The 12th Annual Harvey H. Sigman Lecture in Surgical Education was held on November 17, 2016 with Dr. Daniel B. Jones, Professor and Vice Chair of Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, as guest speaker on the topic of Safer Surgery withSimulation.

Purchase of rectoscopes and biopsy equipment for the Department of Radio-Oncology, to allow for the close monitoring of patients enrolled in the Morpheus study. This study is a new JGH-led randomized study for patients with operable rectal cancer that is testing two innovative strategies to promote cure without surgery but requires a long-surveillance program after treatment with regular rectoscopies and imaging.

“I arrived at the JGH in absolute helplessness. With my left side paralyzed, I could not walk or

stand. The walking jacket made a big difference. It enabled me to take the first step towards my

regeneration and a new life. It gave me the confidence that everything

will be OK again.”

– Lloyd-Nicholas Davis.

65 years oldLloyd-Nicholas Davis

practices walkingwith physiotherapist

Reshmi Varghese.

THERE SHOULD BEAN APP FOR THAT:

The Promise of Technologyfor Mental Health


Support for the McGill Nursing Collaborative for Education and Innovation in Patient- and Family-Centered Care, a unique donor-supported partnership between the Ingram School of Nursing at McGill and the Nursing Departments of the MUHC and the JGH designed to tackle key areas of need in the community. Bringing together practicing nurses with researchers, educators, graduate students and patient representatives, the Collaborative focuses on evidence-based clinical research to improve the quality of care and outcomes for patients and their families, notably in specific patient populations (i.e. helping new mothers with breastfeeding, caring for teens with body image issues during cancer treatments, managing pain in critically ill patients, etc.). Its ultimate goal is to increase the national and international impact of McGill’s Nursing’s programs of research and education and also McGill’s model of clinical practice, and help make Montreal one of the top five metropolises in the world for academic nursing.

Ongoing financial support for the Lady Davis Institute (LDI) and its research into the causes and potential treatments for the most common illnesses—notably, leading-edge clinical work and research by members of the LDI Cancer Research Axis as well as of:

Dr. Marc Afilalo(emergency medicine)

Dr. Jonathan Afilalo(frailty and clinical outcomesin cardiac surgery)

Dr. Jason Agulnik(lung cancer)

Dr. John Antoniou(quantitative MRI as a diagnostictool of disc degeneration, tissueengineering of the intervertebraldisc, and total hip arthroplasty)

Dr. Sarit Assouline(novel therapies in patients withleukemia and lymphoma)

Dr. Mark Basik(breast and colon cancers,development of biomarkers)

Dr. Gerald Batist(translational research)

Dr. Olivier Beauchet(Alzheimer disease and impactof art on geriatric patients)

Dr. Simon Bergman(impact of surgery onelderly patients)

Dr. Robin Billick(melanoma)

Dr. Franck Bladou(prostate cancer)

Dr. Mark Blostein(venous thrombosis)

Dr. Jean-François Boileau(breast cancer)

Dr. Lawrence Panasci(chronic lymphocytic leukemia)

Dr. Joel Paris(borderline personality disorder)

Dr. Vahab Soleimani(muscle stem cell function)

Dr. Michael Tamilia(thyroid cancer)

Dr. Mark A. Trifiro(artificial pancreas,Spinobulbar Muscular Atrophy / Kennedy’s Disease)

Dr. Tsafrir Vanounou(pancreatic and liver cancer)

Dr. Té Vuong(colorectal cancer)

Dr. Michael Wichter(cancer)

Dr. Gerasimos J. Zaharatos(DNA vaccines)

Dr. Phyllis Zelkowitz(perinatal mental health)

Dr. Christoph Borchers(proteomics)

Dr. Marylise Boutros(enhanced recovery after colorectalsurgery, colorectal cancer)

Dr. Howard Chertkow(Alzheimer’s disease)

Dr. François DeBlois(Photon and electron beamdosimetry, Stereotacticradiosurgery and Monte Carlotreatment planning and medicalphysics clinical software)

Dr. Julio Faria(colorectal surgery)

Dr. Cristiano Ferrario(breast cancer)

Dr. William Foulkes(cancer genetics)

Dr. Walter Gotlieb(ovarian cancer)

Dr. Mervyn Gornitsky(oral manifestations ofscleroderma)

Dr. Celia Greenwood(colorectal cancer,neuroinformatics big-data)

Dr. Danielle Groleau(mental health benefits ofExpressive Writing interventionsin school settings)

Dr. Michael Hier(head and neck cancer)

Dr. Nathalie Johnson(lymphoma)

Dr. Tina Kader(diabetes)

Dr. Michael Kapusta(diabetic ophthalmology)

Drs. Léon C. van Kempen,Wilson Miller andAlan Spatz(melanoma)

Dr. David Langleben(pulmonary hypertension)

Dr. Andréa LeBlanc(Alzheimer’s disease)

Dr. Caroline Michel(congestive heart failure)

Dr. Elliot Mitmaker(endocrine cancers of thethyroid, parathyroid andadrenal glands)

Dr. Fackson Mwale(quantitative MRI as a diagnostictool of disc degeneration and tissueengineering of the intervertebral disc)

Dr. Alexandre Orthwein(B-cell malignancies, includinglymphoma, leukemia andmultiple myeloma)


YOU HAVE THEPOWER TO HEALCONTRIBUTE

YOU have the power to make a difference.

YOU have the power to ensure that theJGH and its staff have the facilities,equipment and programs they needto deliver excellence.

YOU have the power to help usachieve better health and betterhealthcare for all, now andin the future.

YOU have the power to heal!

VITALInitiatives


Transforming medical care, diagnosis and hospital quality and efficiency through the acquisition of the best information technology. The future of medicine, the ability to measure outcomes and the implementation of best practices are all driven by specialized information systems created for these purposes. Among immediate requirements are the upgrade of the hospital’s Citrix system, providing clinicians with instant access to patient informa-tion as they roam across facilities, devices and networks; the purchase of a Virtual Desktop Infra-structure (VDI) software program to create efficiency and speed for our doctors' access to patient information; and the acquisition of an essential radiology management system.

Renovation of the Psychiatry Inpatient Unit, which will provide a safer, more secure and functional environment for psychiatric inpatients and for staff. At the same time, the stress on family mem-bers will be reduced, knowing that their loved ones are being cared for in an environment that promotes healing.

Building of the Day Hospital of the Department of Psychiatry, which will enable patients experienc-ing a mental health crisis to receive immediate care instead of waiting at the Emergency Depart-ment. The goals of Day Hospital treatment are to treat acute symptoms and to help the patient function as autonomously as possible again through individual, occupational therapy and various group therapies.

Phase 2 of the relocation, consolidation and expansion of the Sandra & Steven Mintz Nephrology Centre in a single, larger area. This will streamline services and allow for the addition of hemodialysis stations and centralization of kidney treatment services, offices and clinics, ensuring the provision of life-saving treatments to the growing number of patients with kidney disease.

Ongoing support for the critically acclaimed Program for Alzheimer’s disease and dementia (PADD) and the JGH/McGill Memory Clinic. The clinic is the largest of its kind in Canada and provides unparalleled expertise in the early diag-nosis and treatment of memory disorders and dementia.

The achievements resulting from the Power to Heal campaign are wonderful examples of how the JGH Foundation enters into partnerships with committed donors to build on the government’s basic funding and improve access while providing the best care for all. Thousands of patients and their loved ones have benefited from these major advances, and many more stand to benefit, as the Foundation continues to empower the JGH staff to excel.

Maintaining the highest quality of care and meeting the healthcare needs of the population are becoming more and more challenging in the wake of severe budget cuts and the heavy demand for enhanced treatment, care and accessibility stemming from the rising prevalence of chronic and age-related diseases. These, combined with a serious decline in the budgets and allocations of granting agencies for medical research, are adding to the critical importance of our Foundation’s efforts.

With the renewed support of our community of donors and volunteers, our capital campaign will continue to gain momentum and fuel many more advances that will result in enhanced healthcare outcomes for all patients. Our current vital Initiatives are part of our plan to build the hospital of the future with the very best people, equipment, facilities and programs to meet the changing and ever-increasing healthcare needs of Quebecers and overcome the challenges facing our healthcare system as a whole. The following vital initiatives are currently under way and rely on private support to reach fruition:

Relocation and expansion of the Division of Orthopedics’ Inpatient Nursing Unit and Ambulatory Outpatient Clinic to a more functional space that will promote safety and enhance the care provided to patients with mobility issues.

Creation of an Immune Bowel Disease (IBD) Unit and Rapid Access Clinic to ensure enhanced access, treatment and outcomes for the growing number of people in Canada suffering from IBD, which includes Crohn’s disease and ulcerative colitis.


Critical ongoing support for the Lady Davis Institute and its leading-edge investigations into the causes and potential treatments for the most common illnesses. Donors have the opportunity to support one specific researcher or an entire research axis of the LDI for one to three years.

As part of the third phase in the construction of Pavilion K and with emergency and critical care services now relocated to Pavilion K, additional funds are required to renovate and equip the vacated areas in the main hospital to allow exist-ing services to be expanded or new services to be added. Among these is the addition of a new JGH/LDI Clinical Research Centre, which is being developed with a matching federal government grant. This centre will provide an operating platform for transformative clinical research rang-ing from population-based studies to a multi-disciplinary clinical trials program. It will include the creation of a Healthcare Innovation Incubator and Ideas Lab.

Relocation of the Centre of Excellence in Thrombosis and Anticoagulation Care (CETAC) to a dedicated and expanded facility on the 3rd floor of Pavilion B. This will help to streamline the delivery of care, increase the capacity to train thrombosis fellows and graduate students, and empower world-class research, contributing to reducing the incidence of blood clots and associated disease-related and treatment-related complications. It will also raise awareness about the importance of safe and effective thrombosis prevention and treatment throughout the Quebec healthcare system.

Construction of a 6,000-square-foot subsidized daycare centre that can accommodate 80 children, to facilitate the work-family balance of staff. The availability of this onsite service will play an increasing role in motivating, recruiting and retaining qualified staff in a highly competitive environment.

Expansion and renovation of the Lieberman Family Geriatrics Outpatient Clinic to allow for improved and quicker evaluation, treatment and follow-up services for one of the most vulnerable and fastest growing segments of the population.

Continued growth and improvement of the McGill/JGH Proteomics Centre at the Segal Cancer Centre of the JGH and continued devel-opment of a Canada-wide proteomics network, in collaboration with University of Victoria—paving the way for great progress in the development of new diagnostic tools and innovative, targeted therapies for cancer and, ultimately, many other diseases, including neurodegenerative illnesses (Alzheimer’s disease, Parkinson’s disease), autoim-mune diseases (Multiple Sclerosis, pernicious anemia, rheumatoid arthritis, Type I diabetes, etc.), heart disease, and more. Proteomics uses advanced biotechnology to analyze proteins. It can reveal which proteins have been modified within a mutated gene, pointing to patterns (also called biomarkers) of a particular disease and allowing physicians to devise personalized treat-ments that are most likely to be effective for each individual patient.

Together we do have the POWER TO HEALand make a real difference in the health and

well-being of the many communities weserve. Please visit jghfoundation.org,

where many of these life-affirmingprojects are presented in detail

under the Your Impact tab.

IN ACTIONThroughout the year, the JGH Foundation hosted or benefited from a wide variety of events that called upon allof us to support initiatives that empower the Jewish General Hospital to be at the forefront of scientific discovery, innovation and clinical excellence. This enables the JGH to save lives, improve patients’ quality of life and providethe most vulnerable members of society with the care they need. It is immensely gratifying to know that togetherwe can accomplish great things to help people throughout Montreal and Quebec for many years to come.We acknowledge with gratitude all of the event organizers, participants, supporters and sponsors fortheir commitment and support. Thank you for making a difference!

22nd ANNUAL MCGILLHEAD AND NECK CANCER FUNDRAISER – THE VOICEmcgillheadandneck2016.caMay 11, 2016Event Chair: Dr. Jonathan YoungHonouring Maria andVincenzo GuzzoBenefiting Head and Neck Cancer Research at the JGH

2nd ANNUAL CIBC MINDSTRONG FITNESS EVENTjghmindstrong.comMay 15, 2016Honourary Co-Chairs: Tony Marinaro and Malik ShaheedCo-Chairs: Jodi Mintz and Stacey Herman SereroBenefiting the JGH Department of Psychiatry

The Jewish General Hospital Foundation, the Jewish General Hospital Auxiliary, and Midtown Sanctuaire held their 2nd Annual CIBC MINDSTRONG event on Sunday, May 15, at the Midtown Sanctuaire. This unique fitness and fundraising event was MC'ed by Honourary Co-Presidents Tony Marinaro, TSN690 Montreal Sports Radio Host, and Malik Shaheed, TV Host, Marketer and Social Advocate. It attracted over 200 men and women—aged from 14 to well into their sixties, who had the opportunity to engage at their own pace in energizing exercise

sessions, including yoga, zumba, boot camp, Pilates, spinning, high intensity interval training and tennis, all for a great cause.

CIBC MINDSTRONG raised a fabulous $730,000 net out of gross proceeds of $760,000. This represents a fundraising cost ratio of less than 4%, which makes for one of the most cost efficient fundraising events to be held in Montreal this year. No other event in Quebec has raised awareness and resources for mental health on this scale. Proceeds from CIBC MINDSTRONG went to support the building of the Day Hospital of the Depart-ment of Psychiatry, the renovation of the Inpatient Psychiatry Unit, the addition of a Peer and Family Support Centre as well as many crucial mental health programs which help thousands of patients every year.

The Community


Vincenzo andMaria Guzzo.

Title SponsorCIBC

PartnerMidtown Sanctuaire

Champion SponsorsBell Canada EnterprisesJoie

Triumph SponsorsDorelSusan Raymer and Ben Wygodny

Star SponsorsFelice & Arnold Aaron FoundationFranki & Peter YanofskyPiscine Trévi | Val Mar

Roula & Allan Rossy Family FoundationThe Cola FamilyPipe & Piling SuppliesRegal Confections

Kick-off SponsorsADF Group Inc.AutolandBina & Leonard Ellen Family FoundationContinental Capital Investments Inc.La Fondation Emmanuelle GattusoLeutner Wealth ManagementTEAM CHARLIEViau Foods / Fantino and Mondello


GLORIA’S GIRLS – A MAGICAL NIGHT/SHOW WITH OZ PEARLMAN – THE MENTALISTMay 18, 2016Honourary Chair: Maxine Shapiro-RosenblattChair: Ruth RotemBenefiting the Gloria Shapiro Endowment Fund for Ovarian Cancer

ALL STAR TRIBUTE TO BOB DYLANMay 24, 2016Benefiting the Andrew Besner Fund (cancer research)

2nd LUXURY AVENUE May 31, 2016Honourary President: Isabelle TremblayCo-Chairs: David Bitton, Martin Cauchon, Vincenzo Guzzo and Claude LégerBenefiting the Emergency Department, the Azrieli Heart Centre and the Neuroscience Centre in the new Pavilion K

Under the co-chairmanship of David Bitton, Martin Cauchon, Vincenzo Guzzo and Claude Léger, the 2016 edition of L.A. Luxury Avenue Signature took on an added dimen-sion by combining two events into one. The evening "off-road" event, which took place on March 31, 2016, honoured the world-renowned comedian Gad Elmaleh. Over 400 guests came together at the prestigious Le Salon Richmond 1861 for a "roast" honouring Gad Elmaleh's remarkable 20-year career. The evening, hosted by comedian Rachid Badouri, featured many Québécois humorists and Montreal showbizz celebrities.

This celebration was followed by an adrenaline filled dream day at Circuit ICAR. On May 31, 2016, more than 250 participants had the pleasure of taking the wheel of exotic and powerful cars, enjoying sessions on-track, off-road, karting championships as well as a spectacu-lar helicopter ride around iCAR.

Over and above its glamour, the most extraordinary element of Luxury Avenue is the impact of the funds raised. Both Signature events raced side by side to the finish line and raised $669 200. These funds were used to support the critical care services provided at Pavil-ion K, which is the cornerstone of a concerted effort – by the government, the Hospital and the community – to improve access to life-saving treatment.

Manufacturer SponsorJaguar Land Rover Canada

Diamond SponsorsCinémas GuzzoPiscine Trévi | Val Mar

Platinum SponsorsFondation Jean Meloche et FamilleLe Groupe Montoni Division ConstructionLocation Prime LeasingPeartree Financial Services Ltd.Profusion Immobilier RFR. Elvidge Family Foundation

Gold SponsorsGestion immobilière Quo Vadis inc.La Fondation Famille Nezri

Silver SponsorsBDO Canada LLPCapitales MédiasÉditions Phidal

Galit & Joseph AntebiJYC | Location ImperialJoan & Jean PrevostLes Investissements Davisan Inc.Les Investissements Maju Inc.Michael Dadoun et Daniel AssoulineMIKROSMokko Studio Inc.Nathalie et Laurent AmarRodeo FXSimon LibratiVideo MTL - Dazmo

PartnersICARJuste Pour RireRepublikSeal ProductionsTransfilm International Inc.

24th ANNUAL SILVER STAR MERCEDES-BENZ JGH GOLF CLASSIC, IN HONOUR OF RBCJune 6, 2016Co-Chairs: Louis Clément and Gary Wechsler, FCPA, FCABenefiting the new Sandra & Steven Mintz Nephrology Centre

The Jewish General Hospital Foundation held its 24th Annual JGH Silver Star Mercedes-Benz Golf Classic in honour of Martin Thibodeau, Bruce Kent and Tony Loffreda, from the Royal Bank of Canada. Co-chaired by Louis Clément, Partner at Borden Ladner Gervais S.E.N.C.R.L., S.R.L. and Gary Wechsler, FCPA, FCA, the event attracted hundreds of Montreal’s foremost business and community lead-ers from all backgrounds and age groups for a luxurious day on the golf course.

The marquee event raised $900,000, thanks to the extraordinary commitment and hard work of the honourees, the organizing committee and the many people and institutions who demonstrated their respect and admiration for the Royal Bank of Canada. Proceeds from this year’s edition benefited the relocation, consolidation and expansion of the Sandra & Steven Mintz Nephrology Centre at the JGH, ensuring the provision of life-saving treatments to the growing number of patients with kidney disease.

Since its inception, the Golf Classic has raised close to $19 million to improve the medical care, life expectancy and quality of life of the people of Montreal, Quebec and beyond.

HostSilver Star Mercedes-Benz

Major SponsorsBruce Kent GroupDesjardinsInvescoKPMGLes aliments Unifood Inc.,PearTreeScotia Wealth Management (Lambert, Klimis & Sakkas)Louise Wendling and Morris Shamis

Classic SponsorsAimiaBLG - Borden Ladner GervaisDorelGroupe CopleyGroupe MarcelleThe Honourable and Mrs. E. Leo KolberJoan and Jean PrévostR.A. Utting & Associates Inc.Scotia McLeodSpiegel SohmerLillian Vineberg and Morris GoodmanThe Wechsler Family

DonationsCentre d'achats BeauwardFelicia and Arnold Aaron FoundationDr. Gershon FrischRBC FoundationRBC Wealth Management ServicesEllie and Howard Shulkin


The Golf Classic’s three honorees (from left):Martin Thibodeau, Regional President, British Columbia, Royal Bank of Canada,Bruce Kent, Vice President and Director, Portfolio Manager,RBC Wealth Management / RBC Dominion Securities Inc., andTony Loffreda, Vice-Chairman, RBC Wealth Management.

THE FRIENDS OF DR. VUONGJune 8, 2016Organized by Claude Krynski and the JGH FoundationHonouree: Dr. Té Vuong, Chief of the Division ofRadiation OncologyBenefiting Dr. Vuong’s research on Intraoperative Radiation Therapy for the treatment of early-stage breast cancers

Dr. Té Vuong with Renée and Pierre Béland.

8th ENBRIDGE RIDE TO CONQUER CANCER conquercancer.ca July 9-10, 2016Co-Chairs: Andrew Rubin and Dominique Vincent Benefiting cancer research, treatment, care and prevention programs at the Segal Cancer Centre

The 8th Annual Enbridge Ride to Conquer Cancer saw 1,222 riders from across the province set out on their annual trek from Montreal to Quebec City this past July 9 and 10 and raise over $4.4 million for the Segal Cancer Centre at the JGH. Spirits (and temperatures) were high as the participants cycled through the picturesque Quebec countryside supported by hundreds of volun-teers and well-wishers along the route. Funds raised through Quebec’s largest cycling fundraiser support vital cancer research, treatment, care and prevention programs at the JGH and its partners across Quebec.

In the past eight years, the Enbridge Ride to Conquer Cancer has raised over $46 million for cancer programs at the Jewish General Hospital and its partners.

THE ETHNIC SHOW – JUST FOR LAUGHSJuly 26, 2016In collaboration with the Cedars Cancer Foundation at the MUHC, the St-Mary's Hospital Foundation and McGill University.Benefiting the Rossy Cancer Network (RCN)

ONEWALK TO CONQUER CANCER - onewalk.ca August 20, 2016Honourary Co-Chairs: Emmelle and Alvin SegalHonourary Patron: Marina OrsiniCo-Chairs: Sylvie Demers and Louise RobyBenefiting cancer research, treatments and prevention at the Segal Cancer Center

In 2016-17, the Weekend to End Women’s Cancers was rebranded as the OneWalk to Conquer Cancer and its scope broadened to allow walkers to support research for all cancers moving forward. One of the most impor-tant changes was to allow each walker to raised funds for a specific cancer type and/or program they most care about, such as: personalized cancer medicine; breast & gynaecologic cancers; genitourinary cancer including prostate cancer; head & neck cancers; lung cancer; hema-tologic cancers including leukemia and lymphoma; gastrointestinal cancers; skin cancer; the Adolescent and Young Adult Oncology Program; and the CancerNutrition and Rehabilitation Program.

The first edition of OneWalk was held on August 20 and drew 800 participants who enjoyed a one-day, 25-kilometer walk through Montreal’s picturesque streets and communities. Collectively participants raised $1.6 million to support life-saving cancer research, treatment, care and prevention programs for all cancers at the Segal Cancer Centre.

In all, the OneWalk together with the 12 editions of the Weekend to End Women’s Cancers have brought in a grand total of $60 million for the Segal Cancer Centre—contributing to the recruitment of top researchers, the purchase of leading-edge equipment, the development of innovative treatments, the improvement of nursing care and so much more. Participants can derive much satisfaction from the knowledge that they have altered and improved the lives of cancer patients across Quebec!

Title PartnerEnbridge

Breakaway PartnersDilawriKPMG

Founding PartnerRoyale

Official PartnersBrowns Shoes FoundationCNDaviesMétéoMédia

Special ThanksMontreal Museum of Fine Arts

Peloton PartnersBrowns Shoes FoundationNorco BicyclesPharmascienceSugoiRBCMackie Group

Special ThanksÉcole Chavigny



GLORIA’S GIRLS – HOLT RENFREW SHOPPING SPREESeptember 27, 2016Organized by the Gloria’s GirlsBenefiting the Gloria’s Girls Compassionate Care Fund

DIMITRIOS BANOUSIS FUNDRAISING CAMPAIGN FOR PULMONARY HYPERTENSION November 2016Organized by the Banousis FamilyBenefiting the Dimitrios Banousis PulmonaryHypertension Fund

TONGUE-IN-CHEEK BALL HOCKEY TOURNAMENTNovember 12, 2016 Organized by Erik HeftBenefiting the Head and Neck Oncology Department

4th ANNUAL LE FESTIN DE BABETTE November 3, 2016Organized by Johanne DemersHonouree: Pierre BrosseauBenefiting the research of Dr. Andréa LeBlanc on Alzheimer’s disease in the Molecular and Regenerative Medicine Research Axis at the Lady Davis Institute at the JGH

CELEBRATION IN HONOUR OF SYLVIE TREMBLAYNovember 6, 2016Organized by Sylvie Tremblay's family and friendsBenefiting the Segal Cancer Centre

10th ANNIVERSARY SEGAL CANCER CENTRE GALANovember 15, 2016Honourary Patrons: Emmelle and Alvin SegalCo-Chairs: Charles Sirois and Jonathan Wener, C.M.Benefiting the Segal Cancer Centre

The Jewish General Hospital Foundation’s Gala celebrating the 10th anniversary of the Segal Cancer Centre took place on November 8, 2016 at Arsenal Art Contemporain Gallery, Montreal. Co-chaired by Jonathan Wener (Canderel) and Charles Sirois (Telesystem) with Honourary Patrons Emmelle and Alvin Segal, the elegant event drew over 500 guests, including JGH physicians, researchers, nurses, and community and hospital lead-ers, as well as generous supporters and friends of the Jewish General Hospital.

The Gala raised $1.4 million in support of the Segal Cancer Centre as well as of some clinical trials carried out within the McPeak-Sirois Group of clinical research in breast cancer. The goal of this project, shared by the 4 major Quebec hospital research centres in the fight against breast cancer (JGH, CHU de Quebec, MUHC and CHUM), is to improve care given to patients suffering from breast cancer through better access to clinical trials.

Since it opened in 2006, the Segal Cancer Centre has become the leading cancer treatment centre in Quebec, implementing a focussed and comprehensive approach to fighting cancer through medical treatment, patient care, family support and scientific research. The Centre's research and innovative models of cancer care are now recognized on an international level and the Centre has become a magnet for cancer patients across Quebec. It welcomed over 20,000 patients last year alone.

(From left)Kiron Mondal, Pierre Brosseau, Dr. Andréa LeBlanc and Julien Billot.

We thank the many individuals, companies and groups whose generosity and commitment have contributed to the great success of the Gala. Thanks to the incredible support of our generous donors, the Segal Cancer Centre’s teams of caregivers and scientists will continue their vital work to find a cure for cancer.

RIBERA ASSOCIATION GALA – RIBERA FIGHTS CANCERNovember 19, 2016Organized by theFailla FamilyBenefiting the Divisionof Colorectal Surgery

CHANTER NOËL POUR LA RECHERCHENovember 20, 2016Organized byJohanne Champoux and Jacques ParisienBenefiting Dr. Mark Basik’s research onbreast cancer

Event SponsorEmmelle and Alvin Segal

Lead SponsorDesjardins

Diamond Sponsors Dorel Industries Inc. Guerrera Family | Tedeschi Family Brenda & Samuel Gewurz Mia & David Goodman Alta & Harvey Levenson | La Cie Électrique Britton Ltée | Media Experts Monit | Toulon PearTree Financial Services Jane & Herschel Segal Telesystem The Adelson and Marcovitz Families The Honourable & Mrs. E. Leo Kolber Susan & Jonathan Wener

Wine SponsorTina & David Cytrynbaum

Platinum SponsorTerry and Stephen Kaplan

Gold Sponsors AIG Canada | BFL Canada André Azzi Financial Services Inc. Arthur Z. Rubin & Associates Harry & Nancy Bloomfield | Raphael & Evelyn Schachter BMO Groupe financier Border Ladner Gervais | Wechsler Family Bruce Kent Group – RBC Dominions Securities Inc. Cadillac Fairview Delmar International Inc. Mitzi & Mel Dobrin Family Elaine and Richard Dubrovsky Jarislowsky Fraser Ltée.Rhona and Irwin Kramer

Nan & William Lassner | Vivian & Howard Stotland | Merle & Bernard Stotland Metro inc. Olymbec Investments Inc. RBC RD International Richter The Bellini Foundation The Penny & Gordon Echenberg Family Foundation Tidan Hospitality and Real Estate Group Xerox Canada Ltd

Donors ALDO Banque Nationale Anna Brojde CAE Inc. Claridge Joanne & Douglas Cohen Cogeco Corporation Fiera Capital Dalfen Family Foundation Deloitte Felicia and Arnold Aaron Foundation Marcia Gillman & Michael Flinker Beryl & Peter Fraenkel Joseph Ribkoff Inc. Maxwell Cummings Family Foundation Multi Bag Imports Inc. Norton Rose Fulbright Barbara & Stanley Plotnick Jane & Larry Plotnick Power Corporation du Canada Purolator Inc. Susan Raymer & Ben Wygodny Saputo Inc. Union Lighting & Home Verley and Lawrence Yanofsky z”l


(From left) Mark Lazare, Eileen Ramos, Joel Segal, Alvin Segal,Emmelle Segal, Barbara Segal and Harriet Lazare.

Elisa Failla with herhusband, Sebastiano Iacono.

6th ANNUAL PULMONARY HYPERTENSIONWALK FOR BREATHNovember 27, 2016Organized by Dr. David Langleben and theDivision of CardiologyBenefiting the Pulmonary Hypertension Laboratory

The Foundation’s revenue comes from four main streams: the Power to Heal capital campaign, the results of which are presented on pages 5 to 19; the contributions garnered from our annual direct mail program; tribute funds; and events.

Our annual direct mail program brought in $1,269,139.98 in donations, which is slightly higher than last year, while 3,137 people enjoyed the benefits of membership in our Governors’ Circle. Our tribute funds, which comprise Honour Funds that celebrate a milestone in someone’s life, and Memorial Funds, established in the memory ofa loved one, raised $992,203.42. Planned gifts in theform of bequests resulted in additional revenues of $9,818,316.01, a huge increase compared to last year. Online donations grew to $699,512.39.

The other major source of revenue comes from events, some of which have declined year to year as they reach the end of their anticipated life cycle.

The 2016 Enbridge Ride to Conquer Cancer, now in its eighth year, brought together 1,222 dedicated cyclists from across the province who completed the demanding but rewarding two-day, 230 kilometre journey across southern Quebec. They raised $4.4 million in support of cancer research, prevention and treatment at the Segal Cancer Centre at the JGH, and at the University of Quebec Hospital Centre and the Trois-Rivières Regional Hospital Centre.

The 12th edition of the Weekend to End Women’s Cancers, now called the OneWalk to Conquer Cancer, brought together 800 walkers who collectively raised $1.6 million in support of cancer research, prevention, diagnosis and treatment at the Segal Cancer Centre at the JGH. Together, these events brought in a grand total of close to $60 million since the inception of the Weekend to End Women’s Cancers in 2004.

Other major events hosted by the Foundation during the year also benefited from the leadership, commitment and hard work of devoted and passionate chairs, volunteers and participants who rallied support from every sector of Montreal and beyond. Together these signature events and those organized by grateful patients and otherinterested third parties grossed $5,845,682.11, whichrepresents a sizeable increase of 32.9%.

The Foundation contributed over $7.6 million from endowments and other sources for research and academic support, $13.5 million for patient programs and services, and $8.2 million for the purchase of equipment as well as the construction and renovation of installations within the hospital.

18th ANNUAL AHEPA SAINT-VALENTINE’S DAY BALLFebruary 10, 2017Honourary Chair: George SakkasCo-Chairs: James Hutchison and Georgia TridimasOrganized by the American Hellenic Educational Progressive Association (AHEPA)Benefiting the Karen & Murray Dalfen NeonatalIntensive Care Unit

FLY WITH ME GALAFebruary 18, 2017Organized byMary Spina-Menghiand Tonie MauroBenefiting Lymphoma Research at the JGH

SAINT-MICHAEL'S ANGELS BENEFIT EVENINGMarch 11, 2017Organized by Alice and Angelo RibeiroBenefiting cancer research at the JGH

PARACHUTÉ SUR SCÈNE – ONE MAN SHOWMarch 22, 2017Organized by Alex FredoBenefiting the 2017 CIBC MINDSTRONG fitness event


Joseph Palmieri with Tonie Mauro(left) and Mary Spina-Menghi.

FinancialHighlights

2017

$

32,723,607

16,731,091

129,845,758

1,062,906

-

70,351,600

9,014,975

259,729,937

198,556

789,905

73,026,295

5,297,122

1,841,716

81,153,594

162,630,519

15,945,824

178,576,343

259,729,937

2016

$

25,015,561

14,598,499

119,241,406

882,111

-

54,172,145

8,967,719

222,877,441

567,291

77,757

54,132,976

5,468,898

-

60,246,922

180,072,936

(17,442,417)

162,630,519

222,877,441

Assets

Cash and cash equivalents

Marketable securities, at quoted values

Fixed income securities

Equities

Interest and sundry receivables

Advances to Hospital

Pledges receivable

Property and equipment

Liabilities

Sundry liabilities

Due to Hospital

Deferred pledges and contributions

Long-term debt

Promissary note to the Hospital

Fund Balances

Balance - beginning of year

Excess of revenues over expenses and allocations

Balance - End of Year

Financial ReportSir Mortimer B. Davis Jewish General Hospital Foundation

Summarized Statement of Financial Position For the Year Ended March 31, 2017



Financial ReportSir Mortimer B. Davis Jewish General Hospital Foundation

Summarized Statement of Earnings For the Year Ended March 31, 2017

Donations and Fundraising Revenue

Donations and fundraising

Net transfers from (to) deferred contributions

Other Revenue

Usufruct income from Hospital

Accrued revenue

Total Revenue

Expenses

Activities and campaign

Administration

Interest on long-term debt

Amortization

Net income before investment income and allocations

Investment Portfolio Return

Investment Income

Unrealized increase in value of marketable securities

Net Operating Income

Allocations to Jewish General Hospital & Other

Research and academic enhancement

Allocation for research projects

Capital projects and equipment

Other Hospital activities

Endowment Allocation

Other establishments

Excess of Revenues Over Expenses & Allocations

2017

$

38,191,489

2,121,658

40,313,147

366,000

1,838,059

2,204,059

42,517,206

8,015,156

2,606,658

188,673

226,794

11,037,281

31,479,925

12,373,465

2,047,199

14,420,664

45,900,589

5,757,345

1,841,716

8,183,967

10,706,817

2,810,915

654,005

29,954,765

15,945,824

2016

$

32,730,358

(1,228,519)

31,501,839

366,000

18,045,756

18,411,756

49,913,595

7,328,901

2,306,321

194,573

226,794

10,056,589

39,857,006

(14,475,435)

10,931,139

(3,544,296)

36,312,710

4,733,411

38,231,824

6,895,746

2,967,105

927,041

53,755,127

(17,442,417)

OfficersImmediate Past ChairHoward Dermer

ChairEdward Wiltzer

PresidentMyer Bick

Vice-ChairsGerald IssenmanHarvey Levenson

SecretaryPierre Brosseau

TreasurerIrwin Kramer, CPA, CA

Ad-HocAlice RabyRonny SteinbergGary Wechsler, FCPA, FCA

Board of DirectorsDirector EmeritusMorton Brownstein, C.M. (deceased)Sheila Kussner, O.C., O.Q.

Honourary ChairsRichard DubrovskyBernard Stotland, FCPA, FCA

Pierre Brosseau André B. Charron Rona Davis Howard Dermer Aaron Fima, CPA, CA Sylvie GrégoirePascale Hasen Gerald Issenman Mitchell Kendall Joel King/Marlene King (representing Hope & Cope) Perry Kliot Irwin Kramer, CPA, CAReisa Lerner/Beatrice Lewis (representing the Auxiliary) Miles LeutnerHarvey LevensonElliot Lifson Christine Marchildon Jean Prévost Alice Raby Brenda RosenbergAlan Rossy Sarah Rubin

Officers and Board ofDirectors, 2016-2017


George Sakkas Joel Segal Ronny Steinberg Peter Triassi Demetrios Trifonopoulos Gary Wechsler, FCPA, FCA Edward Wiltzer Heleena Wiltzer

Executive CommitteeChairEdward Wiltzer

Vice ChairsGerald IssenmanHarvey Levenson

SecretaryPierre Brosseau

TreasurerIrwin Kramer, CPA, CA

Foundation President and C.E.O.Myer Bick

Hospital Executive DirectorDr. Lawrence Rosenberg

Ad-Hoc (ex-officio)Alice RabyRonny SteinbergGary Wechsler, FCPA, FCA

TrusteesJordan Aberman Marcel Adams Armand Afilalo James Alexander John Alper Joseph BasmajiAnne-Marie Bélanger, CPA, CAWilliam BellLison Benarroch David Bensadoun Danielle Bitton Gabriel Bitton Ronald Black Evelyn Bloomfield-Schachter L. Michael Blumenstein Garner Bornstein Perry Britton Anna BrojdeClaudine Bronfman Stephen R. Bronfman Bernice Brownstein

Janis BrownsteinMichael BrownsteinAndré Bureau Bobby Ciricillo Stanley Cons Steven Cummings, C.M. Murray Dalfen Robert Davis François de Gaspé BeaubienJean Pierre Desrosiers, FCPA, FCA Lewis Dobrin Elaine Dubrovsky Gordon Echenberg Bina Ellen Dr. Sheldon Elman Sam Eltes Lloyd Feldman Aaron Fish Michael Flinker Ron Friedman Mortimer Fruchter James GarfinkleBrahm Gelfand Samuel Gewurz Gail Goldfarb Karp Beryl Goldman David Goodman Morris Goodman Harold Sonny Gordon David Granofsky Saryl Gross Stephen Gross Diane Proulx Guerrera Salvatore Guerrera Thomas O. Hecht Helaine HermanNorman Issley George Itzkovitz Lynne Kassie Bruce Kent Andy Kirstein Max Konigsberg Avi Krispine Jean-Alexandre Lambert Marc Larente Nan Lassner William Lassner Howard Levine Ben Levitt Irwin LitvackGerald Litwin Judy Marmerstein Litwin Paul Lowenstein Irving Ludmer Ralph Masella


Ted Matthews, CPA, CA Leonard J. Mendel Lisa Mierins Gary Mintz Jodi Mintz Steven MintzSamuel Minzberg Terry Minzberg Claude Morency Clifford Noonoo Rory Olson Bonnie Ostrov Paul Ostrov D. James Papadimitriou Ross Paperman Selena Paperman Barry Pascal Edward Pascal Joe Paventi William Pencer Maurice Peress Sydney Pinchuk Stanley K. Plotnick Sol Polachek Hyman Polansky Joel Raby Stephen Rapps Susan Raymer Dorothy Reitman, C.M. Howard Richman Giuseppe Rizzolo Harvey Rosenbloom Nancy Rosenfeld Larry Rossy Lyon Sachs Giancarlo Salvo Seymour Samberg Allan Schouela Edouard Schouela Alan Schwartz Martin SchwartzDonald Seal Emmelle SegalE. Stephen Segal Jeff Segel Gilles Sénécal Barry Shapiro Bernard J. Shapiro, O.C. Jeff Solomon Albert Soussan Wendy Spatzner Manya Stendel Richard Stern Howard Stotland John Swidler Danny Taran Irving Teitelbaum Martin Thibodeau Steven Victor, CPA, CAJustin Vineberg Lillian Vineberg Robert Vineberg Neil Weinman Cindy Weinstein Edward Glen WeinsteinJonathan Wener, C.M.

Susan Wener Peter Yanofsky Steven Yaphe Stanley E. Zack Michael Zunenshine

Honourary TrusteesSydney Aptacker Joe Battat Aldo D. Bensadoun, O.C., C.Q. Harry J.F. Bloomfield, Q.C. Michel Boucher Douglas Cohen Joanne Cohen Nancy Cummings Gold Ronald Gallay, FCPA, FCA Marc Gold Lenore Goldfarb, Ph.D. Robert Goldfarb Shirley Goldfarb The Hon. Yoine Goldstein Sam Hornstein The Hon. Pierre Marc Johnson The Hon. E. Leo Kolber, O.C. Jeremy H. Reitman Alvin Cramer Segal, O.C., O.Q. David Sela Nadia Moretto Sela Vanda Treiser Lawrence Yanofsky (Deceased)Sheila Zittrer

Board Committees2016-2017Investment andFinance CommitteeJoel Segal – Chair Myer Bick (ex-officio) Michel Boucher Normand Grégoire Irwin Kramer, CPA, CA Fréderic Martel Allan Schouela Gustavo Wendichansky (ex-officio)Edward Wiltzer (ex-officio)

Audit CommitteeRonny Steinberg – Chair Myer Bick (ex-officio) Clarence Blatt Carrie Bogante (ex-officio) Aaron Fima, CPA, CADavid Goodman Irwin Kramer, CPA, CA Jonathan Kuczer Marc Larente Philip Levi, FCPA, FCA Miles Leutner Clifford Noonoo

Larry Sidel (ex-officio) Edward Victor, FCPA, FCA Steven Victor, CPA, CA Gary Wechsler, FCPA, FCA Gustavo Wendichansky (ex-officio)Edward Wiltzer (ex-officio)Lawrence Yelin Irwin Zelniker

Corporate GovernanceCommitteeHoward Levine – Chair Anne-Marie Bélanger, CPA, CAMyer Bick (ex-officio)Howard DermerBrahm Gelfand (ad-hoc) Sylvie Grégoire Perry Kliot Beverly Kravitz (ad-hoc) Larry Sidel (ex-officio) Justin Vineberg Edward Wiltzer (ex-officio)

Strategic Planning CommitteeHoward Dermer – Chair Myer Bick (ex-officio) Christine Marchildon Joel Segal Larry Sidel (ex-officio) Edward Wiltzer (ex-officio)

Human Resources CommitteeIrwin Kramer, CPA, CA - Chair Myer Bick (ex-officio) Howard Dermer Aaron Fima Larry Sidel (ex-officio)Edward Wiltzer

Nominating CommitteeHarvey Levenson – Chair Myer Bick (ex-officio)Pierre BrosseauHoward Dermer Gerald IssenmanAlice RabyDr. Lawrence RosenbergLarry Sidel (ex-officio)Edward Wiltzer

Grants CommitteeIrwin Kramer, CPA, CA – Chair Myer Bick (ex-officio) Rona Davis Howard Dermer Mitch Kendall Harvey Levenson Larry Sidel (ex-officio) Ronny SteinbergEdward Wiltzer

3755 Côte-Sainte-Catherine Road, A-107Montreal, Quebec H3T 1E2T: 514 340-8251 F: 514 [email protected]

layout engjgh-foundation.s3.amazonaws.com/production/2018/06/27/19/...18 in hebrew letters forms the...

Documents